Cell 184 , 44954511.e19 (2021)
In preclinical studies, BPC-157 has shown a favorable safety profile
Some studies report that even IV GSH may not increase epithelial lining fluid
However, serious adverse effects have been reported, including risk for C-cell tumors, acute pancreatitis, acute gallbladder disease, hypoglycemia, elevated heart rate, renal impairment, hypersensitivity reactions, and suicidal behavior and ideation
PubMed laboratory research record [PMID: 1663474] PubMed record related to this compound for laboratory literature review
Researchers attribute these effects to Epithalons ability to restore normal p53 tumor suppressor gene expression, reduce oncogene activity, and re-normalize the cell cycle checkpoints that become dysregulated in aging tissues